Return to baseline arsenic concentrations after 1 year on gluten‐free diet in children with celiac disease: A prospective cohort study
Abstract Objectives Lifelong adherence to a gluten‐free diet (GFD) is the primary treatment for celiac disease (CeD). Concerns have been raised about increased exposure to contaminants in a GFD because rice, which naturally bioaccumulates arsenic and other environmental contaminants, is commonly used as a substitute for gluten. In this study, we aimed to determine whether elevated urinary arsenic and other heavy metal concentrations, previously observed after 6 months on a GFD, persisted after 12 months on a GFD. Methods Single‐center prospective longitudinal cohort study of children (age 2–18 years) with biopsy‐confirmed CeD who initiated a GFD between January and May 2022. The primary outcome was the change in urinary arsenic concentration between baseline diagnostic endoscopy and 12 months on a GFD. Results Twenty‐one of the 35 (60%) participants provided a follow‐up sample. After 12 months on a GFD, total median urinary arsenic concentration returned to baseline (3.42 vs. 4.93 μg/L, p = 0.17). The median total nail arsenic collection did not differ significantly between endoscopy and 12 months on a GFD samples ( p = 0.56). Only urinary molybdenum concentration was increased between endoscopy and 12 months of a GFD. Conclusions Children with CeD may have increased arsenic exposure as they transition to a GFD, but concentrations return to baseline within 1 year. Future studies are needed to identify dietary contributors and guide strategies to limit excess arsenic exposure.
Authors
- Nan Du (ORCID: https://orcid.org/0000-0002-2728-917X)
- C. H. Baek (ORCID: https://orcid.org/0000-0002-0644-365X)
- Jocelyn A. Silvester (ORCID: https://orcid.org/0000-0002-3615-1666)
- Rachel Rosen (ORCID: https://orcid.org/0000-0003-3949-3060)
- Tracy Punshon (ORCID: https://orcid.org/0000-0003-0782-446X)
Institutions
- Dartmouth College (US)
- Boston Children's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
Publication Details
- Journal
- JPGN Reports
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1002/jpr3.70135
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Teva Pharmaceutical Industries
- Dartmouth College
- Wright Family Foundation
- Dartmouth Cancer Center
- Fondazione Celiachia
- National Institutes of Health
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases